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Since the outbreak of the recent war a number of contributions have been made 
to  the  chemotherapy of  rickettsial  diseases.  Forbisen  (4-41-bis-antipyrine)  and 
toluidine blue (TB) were shown to be active against routine typhus infections in mice 
(1).  Although found to be effective against pulmonary infections in mice with murine 
and  epidemic  rickettsiae,  p-sulfamidobenzamidine  and  p-sulfamidobenzamidoxine 
proved to be both  toxic and  ineffective  in human  cases  of  epidemic  typhus  (2). 
Against murine typhus infections of mice and of chick embryo yolk sacs, penicillin 
was found effective (3, 4), but when tested against Rocky Mountain spotted fever in 
guinea pigs, it showed no activity (5).  Furthermore, in limited trials against human 
cases  of scrub  typhus  (Tsutsugamushi disease)  (6)  and  of epidemic  typhus  (8), 
penicillin was found to be of uncertain value.  A growing  body of evidence testifies 
to the effectiveness against  both  experimental and  naturally occurring infections 
with  various  members  of  the  rickettsial  group  of  still  another  agent,  para- 
aminobenzoic  acid (PABA).  First shown to be active against murine typhus in mice, 
PABA has since been found to be active in experimental infections of animals and of 
embryo yolk sacs with the rickettsiae of epidemic typhus, Rocky Mountain spotted 
fever, and scrub typhus; furthermore, favorable reports have appeared concerning 
its activity in human cases of all three of the last named diseases  (7-16). 
Because of the observations made in this laboratory concerning the effective- 
ness of toluidine blue (TB) in combatting murine typhus infections (1), trials of 
this dye were made against experimental scrub typhus when strains became 
available.  Soon thereafter, stimulated by word that the closely related dye, 
methylene blue  (MB), had also been found active against murine infections 
(17),  investigation  of the  activity of MB  against  scrub  typhus was  begun. 
The demonstration of the chemotherapeutic activity of both TB and MB in 
infections with RickeUsia orientalis  was reported in preliminary form (18) al- 
most coincidentaUy with a report of similar content from an independent source 
(19).  As the result of these reports, therapeutic trials of MB in human cases of 
scrub typhus were conducted in Burma (20), and these revealed that effective 
dosage in man was accompanied by serious toxic manifestations. 
In spite of the unsatisfactory outcome of the human trials, the antirickettsial 
activity  of  these  dyes is so  striking in experimental tsutsugamushi  disease 
as to provoke continued interest.  The present paper extends the previously 
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reported observations as to the results observed in the treatment  of the experi- 
mental diseasewithMB  and TB  (18).  In addition, the occasion has been taken 
to describe briefly, in the section on materials and methods,  certain problems 
related to the experimental disease and the techniques of handling R. orientalis. 
Materials  and  Methods 
Rickettsial  Strains.--Four  strains of R.  orientalis--Raub,  Seerangayee, Queensland, and 
Karp---were used in this study.  The majority of the experiments were done with the last- 
named  strain,  which  was  isolated  in  Australia  by  Dr.  F.M.  Burnet from a soldier who 
presumably had contracted the infection in New Guinea (21).  The Queensland strain was 
isolated from a  bandicoot in Australia by Dr. W. G. Heaslip.  The Paul) and Seerangayee 
strains were isolated from human cases by Dr. R. Lewthwaite in Malaya. 1  The various strains 
had previously been carried in continuous passage in mice, guinea pigs,  or in the anterior 
chamber of the rabbit's eye for periods of months or years.  In this laboratory they have been 
maintained by serial passage in cotton rats or, later, in the yolk sacs of developing eggs. 
Sources of Infectious  Material.--The preliminary observations were made with infectious 
material which consisted of freshly prepared suspensions of tissues, usually liver, of mice or 
cotton rats infected by the intraperitoneal route and sacrificed when obviously ill.  This use 
of fresh material was necessitated by our inability to maintain infectious material in the frozen 
state  (-76°C.)  without marked loss in infectivity.  Later, as had been suggested by  Dr. 
N. H. Topping, it was found that such material could be stored with little loss of titer for 
several months if skim milk was employed as the suspending medium.  Meanwhile these 
strains had been satisfactorily adapted to serial passage in the yolk sac of the developing chick 
embryo, the infective titers of which regularly surpassed those of the animal tissues.  InaUof 
the later work, therefore, the infectious material employed consisted of 20 per cent suspensions 
of pooled yolk sac made in skim milk and stored at -- 76°C.  until used.  Embryos 6 or 7 days 
old were inoculated by the yolk sac method (22) with 0.5 cc. of an approximately 1:50 dilution 
of infected yolk sac of the preceding passage.  Mter 9  to 12 days' additional incubation at 
35°C. the yolk sacs of the surviving embryos (usually from 50 to 65 per cent of those inoculated) 
were harvested, suspended in milk, homogenized in a  Waring blendor, and stored in flame- 
sealed glass ampoules in a dry ice chest.  The infective titer of such yolk sac pools has been 
on the order of 10  -s. 
Diluents.--Because of evidence obtained in this laboratory with typhus rickettsiae (23), 
nutrient broth was  employed as  the diluent in early experiments.  Although this proved 
satisfactory for work, which could be performed rapidly, it was found to be inadequate for the 
maintenance of the infectivity of R. oricntalis during large scale experiments.  Tests for the 
maintenance of infectivity over a 24 hour period (5°C.)  of material with an original infective 
titer of approximately 10  -*-7 revealed losses in titer of one log when the diluents were skim 
milk or 2 per cent normal yolk sac in saline, of 2 logs with 10 per cent human serum in saline, 
of 3 logs with nutrient broth, and of 4 logs with saline.  When distilled water was employed 
infectivity was completely lost.  In the later and by far the greater part of the experiments 
herewith reported, dilutions were made only with sterile skim milk.  As an added precaution, 
all inocula were kept chilled in an ice water bath from the time of dilution until inoculations 
were completed. 
Experimental  Animals.--The  majority  of  the  experiments were  performed with  albino 
Swiss mice obtained from one or another of two commercial breeders.  The remaining work 
was done with Eastern cotton rats (Sigmodon hispidus  hispidus),  also commercially bred. 
1 All four of these strains were acquired by us through the courtesy of Dr. R. Lewthwaite. 0. L. PETERSON  AND  J.  P. ~'OX  545 
Inoculation.--Animals  usually were inoculated by the intraperitoneM route with a volume 
of 0.25  co.  Exceptionally, as indicated in the text, inocula of similar volume were given 
subcutaneously or intravenously, or a volume of 0.03 co. was given intracerebrally. 
Notes on the Mouse Disease.--In experiments with the Karp strain it was observed that 
mice are susceptible, with some uniformity, to lethal infection when inoculated by the intra- 
peritoneal, intravenous, or intraeerebral routes, but are only irregularly susceptible to disease 
induced by subcutaneous infection.  The intranasal route was not employed.  When compa- 
rable series of mice were inoculated by the several routes and observed for lethal outcome it 
was found that the maximum lethal end point followed intraperitoneal inoculation, and that 
the end points in the intravenously and intraeerebrally inoculated animals were respectively 
about 2 and 4 logs less.  In subcutaneously inoculated mice death ensued irregularly over a 
fairly wide range of dilutions, but with no dose did a majority of the mice die. 
Challenge of the surviving mice at 30 days after inoculation, employing a certainly lethal 
intraperitoneal inoculum (10  s to 104 LD~0), revealed an absolute coincidence of the lethal and 
immunizing end points in the intraperitoneally inoculated series.  This observation has been 
repeated a number of times, and the only mice surviving the challenge inocula were occasional 
single mice which survived infection with dilutions below that of the lethal end point.  For 
this reason we believe that the mouse is essentially completely susceptible to intraperitoneal 
infection with the Karp strain.'  In contrast, challenge of the survivors of series inoculated 
by other routes than the intraperitoneal revealed a well demarcated zone of resistance beyond 
the original lethal end point and varying in extent with the route of the original infection.  In 
each case, however, the challenge results permitted the calculation of an immunizing end 
point which did not differ significantly from the lethal end point observed in mice inoculated 
in parallel by the intraperitoneal route. 
Weight and age of the mice did not appear  to  be factors of importance in influencing 
susceptibility.  Increase in ambient temperature has been reported to effect a great increase 
in the resistance of mice to murine  typhus (24).  However, others have found the similarly 
induced resistance of mice to scrub typhus to be of a low order of magnitude (19), and in our 
own experience the warmerweather of the summer months did not interfere with the conduct 
of experiments. 
In intraperitoneally inoculated mice the disease became apparent after from 4 to 17 days, 
depending on the dilution of inoculum employed, and most of the deaths occurred by the 21st 
day.  Cardinal signs of the disease were roughening and matting of the fur, loss of appetite, 
weakness and reduction of activity, bloating of the abdomen and, often, the protrusion of an 
inspissated stool from  the rectum.  Following other routes of infection,  somewhat longer 
incubation periods were noted and eventual recovery of obviously sick mice occurred with 
some frequency.  Mice infected intraeerebrally usually manifested signs of cerebral irritation 
and often died during an attack of extensor spasm. 
Notes on the Cotton Rat Disease.--Like mice, cotton rats were found to be more susceptible 
to intraperitoneal infection, less so to intraeardial and intracerebral infection, and relatively 
resistant to subcutaneous infection.  The susceptibility of these animals was also found to be 
influenced to some extent by size or age and to a greater extent by season.  Larger rats were 
' Much less detailed studies suggest that this conclusion is also valid with respect to the 
other  three  strains employed  in  these  studies;  i.e.,  Raub,  Seerangayee,  and  Queensland. 
Certain strains of R. orientalis which have come into our hands more recently, however, appear 
to be less virulent for mice, in that even relatively large intraperitoneal infecting doses are not 
uniformly lethal and  small doses  ordinarily produce  only an  immunizing infection.  The 
Calcutta and Gilliam strains, yolk-sac adapted, when received by us, were of this type.  In 
both these cases,  however, it has been possible to increase the virulence for mice to some 
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more resistant  than smaller ones and, in marked contrast to the behavior of mice, all rats 
became highly resistant during warm weather.  Even in the winter, however, the susceptibility 
of cotton rats was not as great as that of mice. 
The signs and course of the disease in cotton rats were similar to those in mice, although, 
especially in the case of larger rats, death occasionally was not preceded by detectable signs of 
illness. 
Chemotherapeutic  Agents.  Tol~ine Blue.--Most of the experiments with TB were carried 
out with the zinc salt produced by the National Aniline Division of the Allied Chemical and 
Dye Corporation, a product stated to contain 58 per cent dye.  Later, through the courtesy 
of Mr. J. D. Nantz of that organization, a partially purified preparation was obtained, free 
of zinc, and containing 85 per cent dye in chloride form. 
Methylene BMe.--Except  for one or two preliminary experiments done with a  Griibler's 
preparation  all work with MB was carried out using the medicinal grade marketed by the 
Merck Company. 
Para-Amlnobenzo~ Ac~.--A  PABA preparation  of the Eastman Kodak  Company was 
employed in the acid form, or, in one experiment, converted to the sodium salt by the addition 
of a calculated equivalent of sodium bicarbonate. 
Forbiscn.--Forbisen  (4-4' bis-antipyrine) was supplied by Mr. W. W. Allen of the Dow 
Chemical Company. 
Administra~ien of Dmgs.--In most instances, and unless otherwise stated, drugs were fed 
to mice by incorporating them in a determined concentration, usually 0.25 per cent by weight, 
in ground fox chow.  This mixture was made into a mash by the addition of water and placed 
in the cages in quantities calculated to give each mouse 3 gin. by dry weight of food per day. 
Additional water was supplied by bottles.  Unless otherwise stated, feeding was begun im- 
mediately after inoculation and continued for from 14 to 16 days. 
Presentation of Results.--The routine period of observation was 21 days, and the com- 
putation of results was based upon the number of mice alive at the end of this period.  End 
point determinations have been made by the method of Reed and Muench (25).  Results 
otherwise have been expressed as survival ratios, which are defined as the ratio of the number 
of mice surviving to the number inoculated and surviving through  the incubation period 
(deaths from intercurrent infections were thus in some part excluded).  In some instances 
the presentation of results in the form of such ratios has been supplemented by the calculation 
of the average survival time of the group.  In such calculations, mice surviving have been 
given the arbitrary survival time of 21 days. 
EXPEI~T~NTAL 
Certain facts were rapidly established during preliminary experiments which 
will not be described in detail.  The activity of TB  (0.5 per cent in the diet) 
against a  minimal Karp strain infection in mice was found to exceed greatly 
that of forbisen (1.5 per cent) and of PABA (tested only in 2 per cent concentra- 
tion in the diet).  Toluidine blue was also shown to be active against infections 
in cotton rats with three additional strains of R. orientalis--the  Seerangayee, 
Queensland, and Raub strains.  Subsequently, it was observed that MB also 
was active against Karp strain infections in mice. 
These  observations made it  clear that  the  antirickettsial activity of  TB, 
and presumably of MB as well, could be elicited in at least one animal species 
other than the mouse, and against several rickettsial strains.  To avoid the 
introduction of unnecessary variables, the work to be reported was restricted 
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The Quantitative Limits of Activity of Orally Administered Agents 
The results of the preliminary observations warranted a more precise assay 
of the activity of TB and MB.  Additional experiments with PABA also were 
performed in view of the striking results achieved with that agent in treating 
scrub  typhus infections  in gerbilles  (14, 15).  Important points  to determine 
were the maximum doses of these drugs which could be administered and their 
relative  effectiveness  in  such  concentrations. 
The Tolerance of Mice to Oral Drug AdminislraM~n.--in the work with TB in murine typhus 
infections it was possible to feed mice concentrations  of dye as great as 1.5 per cent for a 5- 
to 8-day feeding period.  In the present  work, however, drug administration  was usually 
continued  for a minimum of 14 days and the maximum concentration  of dye tolerated  was 
much lower.  Although in a few experiments mice tolerated TB in 0.5 per cent concentration, 
consistent  tolerance was observed only with concentrations  of 0.25 per cent or less.  Even 
when the dye used was the zinc-free chloride, higher concentrations proved toxic. 
Essentially the same limitations were found t6 apply also in the case of MB.  Groups of 
16 mice were placed on diets containing  1.0, 0.75, and 0.5 per cent dye and observed for 16 
days.  At the end of this period the only surviving animals were 5 mice in the group fed 0.5 
per Lent dye.  With a level of 0.25 per cent MB, however, little  evidence of toxicity was 
observed, even when feeding was prolonged for 37 days. 
In the case of PABA mice readily tolerated concentrations of 3.0 per cent or of 3.5 per cent 
when the sodium salt was employed.. With concentrations  of 6.0 or 9.0 per cent, however, 
the mice refused to feed. 
Determination of tke Rdati~e E~ectiveness of Drugs.--Admlnistration of all drugs was begun 
immediately after infection and continued for 16 days in the case of MB and TB and for 21 
days in the case of PABA.  In some experiments mice were fed the same drug in different 
concentrations; in others 2 or more drugs were compared; in all of the experiments drug activity 
was measured by employing groups of mice infected with serial tenfold dilutions of infected 
yolk sac and comparing the lethal end points obtained in treated animals with those obtained 
in untreated controls. 
The results of a number of experiments have been presented in Table I.  The 
survival  ratios  observed  afford  a  basis  for  appreciation  of  the  protection 
achieved in each range of infective dose.  In addition, the efficacy of the drugs 
has been given mathematical expression as the log LDs0 of the infectious dose 
against which the agents were effective.  In spite of variations of considerable 
magnitude between  the indices of  effectiveness  observed in different experi- 
ments for the  same drug employed in the  same  concentration,  these  experi- 
ments permit certain conclusions to be drawn. 
Both MB and TB possess a remarkably high order of activity when employed 
in 0.25 per cent concentration.  The activity of MB, which is clearly greater 
than that of TB, was never fully gauged, since the protective effect of the dye 
was not overridden by the maximum infecting doses employed; i.e., about 10  s 
LDs0.  The concentration of dye fed also is important.  By reducing the con- 
centration  to 0.10  per  cent  the  protective  action  was  lowered  more  than  a 
hundredfold. 
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be slight.  Experiment 6 indicates that PABA, even when administered as the 
sodium salt, is some 37 times less active than MB employed in 0.10 per cent 
TABLE I 
The Relatite Effeai~ness of Toluidine Blue, Methylene Blue and Para-Amlnobenzoic  Acid When 
Fed to Mice Infeaed with Graded Doses of Karp Strain R~kettsla 
~,,x- 
peri- 
ment 
No. 
6 
Survival ratios of mice infected with approximate number 
o~ LD60 indicated  Infectious 
Concen-  dose 
i  '  protected  tration  Not  against 
Drug  (per  in-  ca. 10  s  ca. 10  ~ ca. 10  s  ca.  l0  s  ca. 10  4 ca. 10s  ~a. i0~  ca. l0  t  (log LDs0)  cent)  t ected  of diet 
0.25  10/19 16/20 20/20i  7.27 
TB*  0.i  0/20  2/20 10/20  ca. 5.51 
0  0•20  0120 0•20  017  016  018  0/8~  0 
i 
TB*  0.25  3/17 15/18 11/16 15/15 14/14  6.14 
MB  0.25  27/34 27/33 21/30 27/33 25/28  > 6.86 
0  0/17  0/18 0/18 0/11 0/8,  0 
TB§  0.25  19/20 0/2C 9/2016/2GI,  6.52 
0.10  20/20 1/2C  1/20  0/20! 2/20  2/19  <3.80 
MB  0.25  18/19 14/2C 16/20 18/2G  >7.80 
0.10  20/20 1/20 6/19 10/20 10/1916/19  5.47 
0  0/20 0/20 0/10  0/10 1/95  0 
MB  0.10  28/30  2/30 11/28 13/29 15/29 20/30  4.31 
0  i  0]24  0/22  0/23 3]225  0 
PABA  3.0  0/19  0/20  5/20  9120 9/20  <1.41 
(acid)  0  0/19  1/2C 3/205  0 
MB  0.10  0/8  2/8  2/8  8/8  6/8  5.14 
Sodium  3.5  8/8  0/8  0/7  2/8  518  5/8  7/7  3.57  PABA 
PABA 
(acid)  3.0  1/8  2]8  0/8  2/8  2/8  ca. 1.46 
0  o17  o/8  o/7  o185  o 
Treatment 
* Toluldine blue in form of zinc salt, 58 per cent dye. 
5 In each experiment the dilutions in the untreated  control series were carried beyond 
the lethal end point, but the results observed in dilutions containing about 1 LD~0  or less have 
been  omitted  from  the  table. 
§ Toluidine blue in form of chloride, 85 per cent dye. 
concentration.  The recently reported work in gerbilles, however, has empha- 
sized the importance of maintaining adequate blood levels of PABA by sup- 
plementary parenteral injection (14, 15).  Furthermore, work now in progress 
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achieved by supplementing the sodium salt of PABA in the diet with 1 per cent 
sodium PABA, carefully adjusted to pH  7.0, in drinking water supplied ad 
libitum  (26). 
Activity of Methylene Blue against Cerebral Infection.--The neural localization 
of the infection with R. orientalis in man is not uncommon.  To determine the 
effectiveness of MB against a neural infection, a single experiment was carried 
out which differed from those just reported only in that the mice were inoculated 
by the intracerebral route.  The results are presented in Table II.  In spite 
of the lesser virulence of the rickettsiae for mice when injected intracerebrally, 
the dye is much less effective in combatting the resulting primarily neural 
infection.  None the less, it is clear that a  significant protective effect was 
obtained. 
TABLE  II 
Methylene Blue in Treatment of Intracerebrally Infe~ted M~e 
Dilution of Karp-lnfected yolk sac 
10-1.3 
lO-2.s 
lO-a.8 
lO-*.s 
lO-5.s 
10-6.~ 
10- 7.a 
Survival ratios 
MB, 0.25 per cent in diet 
5/16 
8/15 
9/13 
11/13 
Controls 
0/13 
0/16 
5/14 
7/13 
2/8 
8/8 
8/S 
Mortality end points  .............  10  -~'s  10  -4"s 
The  Time  and Duration  of Dye Administration 
The undeniably great antirickettsial activity so far demonstrated for TB 
and MB must be considered prophylactic rather than therapeutic, since treat- 
ment was begun promptly after infection.  The effectiveness of delayed treat- 
ment and the minimum necessary period of treatment remained to be investi- 
gated. 
Effectiveness  of Dyes  When Administration  Is  Delayed.--In  Table III are 
presented the results of experiments with both TB and MB in which feeding 
of the respective dyes was initiated at various intervals after infection.  Against 
infection with 10  *-4s LD~0 of Karp strain rickettsiae, TB in 0.25  per cent con- 
centration was significantly effective when first administered as late as 6 days 
after infection.  When the dye was fed in 0.5 per cent concentration, a similar 
result was obtained.  By the 8th day the mice, already somewhat sick, had 
nearly stopped eating and so ingested little or no dye.  In the second experi- 
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ening of the incubation period.  Since some mice were already slightly sick by 
the 6th day post infection, the feeding of MB begun at this time was of di- 
minished but still significant effect.  In another experiment, not includedin 
the table, 15 mice infected with 10  3 LD~0 were fed upon an MB diet for the first 
time on the 10th day post infection when 12 already showed signs of illness. 
Five of these mice survived, although all of 12 controls succumbed.  Attempts 
to initiate treatment at still later stages in the disease, either by stomach tube 
or by parenteral means, were uniformly unsuccessful. 
The importance of the results obtained in Experiment 2, Table III, is en- 
hanced by supplementary observations made  as to  the  development of the 
infection in untreated control animals, some of which were sacrificed at inter- 
vals after infection.  By 4 days post infection tbe blood was clearly infectious 
TABLE HI 
Effectiveness of Delayed Administralion of Toluidine Blue and Megkylene Blue in Mice Infected 
witk Karp Strain Rickettsiae 
Experi- 
ment  Treatment 
lq'o. 
T~ 
0.25 per cent 
I  TB 
0,5 per cent 
No TB 
MB 
2  0.25 per cent 
No MB 
hallen 
dose 
LDs~ 
0 
10~.~ 
0 
10~4a 
lO~.U 
104.t 
10~.~ 
Survival ratios of mice on which treatment was begun on 
designated day post inoculation 
14/20  1 
!19120[  19/2C 
,15/20 
o/18 
114/18 
o/211 
16/20  19/2~ 
13/2~ 
'2( 
13/2( 
ll/lg 
14/20 
15/20 
8/2C 
[  8 
[ 1/20 
I 
1/20 
2/20  0/20 
10 
0/20 
1/20 
and the infectivity titer of the liver was 10-4.~s; by the 7th day the liver titer 
had risen to 10  -e.3.  It thus is evident that treatment with MB, and presumably 
also with TB, was effective when initiated after the development of systemic 
infection.  These dyes accordingly may safely be said to possess therapeutic 
activity. 
Determination of the Minimum Necessary Period of Dye Administration.--The 
period of administration of MB at the maximum tolerated level necessary to 
afford a maximum therapeutic result in experimental infections must be deter- 
mined by the size of the infecting dose and the time of initiation of treatment. 
A survey of the interrelation of these factors should yield information directly 
bearing on the treatment of the human disease. 
Of the several experiments performed, the three which are outlined in Table IV afford results 
which are directly comparable.  The mice employed were from the same source and of 
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ground fox chow, was identical in all.  In the first experiment mice were inoculated with a 
large (10  e.4s LDt0) or a small (10  ~.~s LDso) infecting dose and placed on treatment at once. In 
' the second experiment a single infecting dose (10  ~.*s LDt0) was employed, but the mice were 
not given MB until the 3rd or the 6th day.  In the third experiment treatment was withheld 
until the 7th day after an infecting dose which, on the basis of the control titration, was 
10  tas LDto but which, on the basis of the average survival time of the untreated control mice, 
behaved as a slightly smaller dose than that employed in the second experiment.  In these 
latter two experiments supplementary observations as to the development of infection prior 
to treatment were made by sacrificing representative mice in groups of four and determining 
the presence of the infecting agent in the blood (at daily intervals) and the actual infective 
level of the liver (on the days that treatment was begun).  At various intervals up to the 17th 
day post infection, groups of 20 mice in each treated series were changed to normal diet.  The 
results are presented as the survival ratios determined on the 28th day post infection.  For 
TABLE IV 
E~e~t of Systematic Withdrawal of Methylene Blue flora  Mice Infec~d ~h  Di.ffe~ent  Doses 
of Karp Strain RicktCtsiae  or Placed on Dye Treatment at Intervals after Infection 
per/" 
ment 
NO. 
nfectiv 
~  titer of 
Hvers* 
•  on day 
m  MB die 
un  was 
begun 
10-~ 
10-~.o~ 
10-t 
Survival ratios of mice changed to normal diet on indicated day 
post inoculation 
O/2O 
J, 
0/20 
0/20 
o12o 
o/2o 
21 
I 
i 
5/20 
4  5 
t4/20 
3/2C  4/19 
6  8 
19/19 
12/18 
2/19  12/19 
o/19 
$ 
I 
0/20 
10  11  12  14  17 
16/1~  16/17 
t512o  17/18  1711", 
ts/~  17/19 19/lo zl~ 
L9/~  14/80 'ag/~ rs/~ 
4/1~  'UlAO ~/~  14/~ 
* Observations made on pooled tissues of 4 mice selected at random for sacrifice just prior 
to institution of MB diet. 
Indicates time treatment with MB was initiated. 
convenience, those survival ratios which represent essentially the maximum effect in each 
series are shown in boldface type in Table IV. 
From the first experiment it appears, somewhat surprisingly, that the period 
of  dye  administration necessary to  insure maximum protection against the 
smaller dose  (from 12  to  14 days) is significantly longer than the period ne- 
cessary  (8 days)  in the case of the dose ten thousand times more infective. 
From Experiments 2 and 3, in which nearly identical infecting doses were em- 
ployed, it appears that the time of initiation of treatment is more important 
than the time of withdrawal in determining  the therapeutic effectiveness of MB. 
Treatment continued  beyond the 10th or 12th day did not result in an increased 
survival rate in any series even though the time of initiation  of treatment varied 
between the 3rd and the 7th day.  On the other hand the maximum survival 
rates  achieved  varied  inversely  with  the  day  on  which  dye  was  tint 552  CKE~[OTHERAPY OF SCRUB TYPHUS 
administered.  Thus, the survival rates among mice continued  on  treatment 
to the 17th day were 97, 50, and 36 per cent when treatment was begun on the 
3rd,  6th,  and  7th day, respectively.  The associated observations as  to  the 
infectivity of the blood (constant from the 3rd day on) and of the liver (shown 
in Table IV) indicate in each case that the infection was systemic at the time 
treatment was initiated. 
The results just described suggest that the safe withdrawal of therapy de- 
pends not upon its previous duration but upon some aspect of the infection 
which evolves more rapidly when the infecting dose is large than when it is 
small.  As shown in the following paper, the evolution of the infection proceeds 
in the face of adequate treatment.  The results of an experiment not otherwise 
of present interest  3 indicate that the immune reaction develops more rapidly 
following a  larger infecting dose.  A reasonable hypothesis, therefore, is that 
treatment may safely be discontinued after the onset of the immune reaction. 
In the absence of a satisfactory means of determining this point in the human 
infection,  the  practical  conclusion is  that  unconsidered prolongation of dye 
therapy, at least beyond the usual duration of the disease, cannot be expected 
to contribute to the cure. 
Parenteral Administration  of Methylene Blue 
The oral route of dye administration had been chosen and subsequently ad- 
hered to because of its simplicity, its remarkable effectiveness, and the great 
degree of tolerance exhibited by mice to dye so administered.  Human treat- 
ment by this method was envisioned, although calculations on a relative weight 
basis suggested that the indicated human dose would be huge; ~.e., over 20 gin. 
a day.  As the result of a single observation within our own experience  4 which 
was soon more than confirmed by field  trials in a  series  of 24 cases  (20),  it 
appeared that the capacity of MB to irritate the gastrointestinal tract, as mani- 
fested by the stimulation of vomiting and diarrhea, limited the daily tolerated 
intake to doses of less than 3 gm. even when taken in small portions at intervals 
of 2 hours.  This dose appeared to exert no significant influence on the course 
of the human disease.  Our attention,  therefore, was turned to investigating 
the  effectiveness  of dye administered  parenterally. 
: Observations on t'ke Toxicity  of Parenterally  Administered  Methylene  Blue.--Preliminary 
tests Of the aettte toxicity of MB for normal mice of 12 to 15 gin. indicated the approximate 
~  Animals infected subcutaneously in large part  survive and rather rapidly develop re- 
sistance to regularly lethal intraperitoneal challenge.  It was noted that, following  a primary 
subcutaneous infection of 10  a LD~0, some mice challenged as early as the 2nd and the 5th day 
l~mved resistant, whereas after a primary infecting dose of but 10  ~  LD60, resistance was first 
61JServed among mice challenged on the 8th day. 
• 4  Case of suspected laboratory infection, later shown to be of non-rickettsial nature, but 
treated with MB at outset at our suggestion by Dr. Wa!sh J. McDermott of the New York 
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LD~o to be 2.5 rag. administered subcutaneously and slightly over 1.25 rag. given intravenously. 
Because of its greater convenience the subcutaneous route was selected for experimental pur- 
poses.  With the maximum tolerated daily dose of approximately 1 rag.  (determined for a 
10- to 12-day period of administration) few tissue sloughs were observed when the site of in- 
oetdation was sufficiently varied from day to day.  In these and in all subsequent experiments, 
the amount of dye administered was contained in a  single inoculum of 0.25 ml. 
The possibility that susceptibility to the toxic action of the dye may increase as the infectiorr 
evolves also was investigated because of its obvious pertinence to  the problem of delayed 
therapy.  In two  separate experiments employing relatively large groups  of infected mice, 
susceptibility to the toxic effects of MB was shown to increase, on the order of twofold, in 
the terminal 2 days of infection. 
TABLE  V 
The Effecti~ne.ss of Methylene Blue Administered Subcutaneously to Mice Infected with Karp 
Strain Rickettsiae 
Experimeat 
Infecting 
No.  dose (LD~o) 
10s.6 
1 
I0' 
2 
Treatment*  Survival Ratios 
Route 
Subcutaneous 
No methylene blue 
Oral 
Subcutaneous 
No methylene blue 
Infected mice started on 
treatment on designated 
Daily  day post infection  dose 
mg 
1.125 
0.75 
0.375 
7.5 
3.0 
1.0 
0.5 
3  5  7 
8/16  8/16  3/16 
3/16  2/16  1/16 
1/16  0/16  0/16 
o/16  --  -- 
24/27  22/27  -- 
12/27  4/28  -- 
10/27  1/28  -- 
0/26  1/28  0/18 
0/29 
Uninfected 
controls; 
treatment 
begun on 
3rd day 
14/16 
16/16 
17/18 
14/28 
* In all cases treatment was discontinued on the 12th day. 
The Therapeutic  Effect of Parenterally  Administered Methylene  Btue.--As a 
preliminary trial some of the infected mice surviving the tests of dye toxicity 
were carried on a daily regime of 0.625 rag. of MB given subcutaneously until 
the 13th day.  Such treatment begun on the 3rd, 6th, and 8th days resulted in 
the respective  survival of 17 in 36, 8 in 23, and 0 in 28 mice.  Evidently some 
degree of therapeutic effect could be achieved by subcutaneous administration 
of MB. 
Two experiments  serve  to  illustrate the results  of further exploration of 
parenteral  therapy.  The  pertinent  experimental  details  of  these  and  the 
results are indicated in Table V.  Apparently because  the mice employed in 
Experiment  1 were  3  weeks  older  and  correspondingly  heavier than  those 
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apeutic  effect  achieved were  greater  than  in  any subsequent  experiment. 
Experiment 2, in which added groups of mice were placed on oral treatment 
regimes for comparative purposes,  yielded more  typical results.  The effec- 
tiveness of maximal tolerated oral dosages (7.5 mg. daily) clearly surpasses that 
of regimes based on subcutaneous administration of dye, even when toxic or 
near toxic dosages are employed.  Certainly non-toxic  subcutaneous dosages 
were of little or no therapeutic effect. 
DISCUSSION 
The  evidence  herewith  presented  conclusively  demonstrates  that,  when 
incorporated in the diet in suitable concentrations, two dyes of the thioninc 
series,  toluidine blue  (TB)  and methylene blue (MB), possess a  remarkable 
ability to protect mice against the usual lethal outcome of intraperitoneally 
induced infection with the Karp strain of R. orientalis.  That this effectiveness 
is manifested in cotton rats and against three other strains of rickettsiae also 
has been indicated.  Of the two dyes, MB possesses the greater activity  and has 
proved capable of protecting a majority of mice infected with the maximal doses 
employed; i.e., about l0  sLDS0.  Furthermore, this activity is truly therapeutic, 
since treatment  with either dye proved significantly  effective when delayed until 
a systemic infection had become well established.  These results are confirmed 
by similar observations with MB made independently  by another group (19). 
The observation that MB possesses activity against cerebral infection is of 
interest, since it suggests that one of the complications  of the human disease, 
neural involvement, may be favorably influenced by treatment.  Observations 
to be reported in the second paper of this series give this presumption additional 
support, since it was found that the localization, multiplication, and persistence 
of rickettsiae in the brain are greatly influenced by the administration of MB. 
The early observations of the remarkable effectiveness  of MB in treating 
experimental infections with R. orientalis led, naturally, to human trials (20) 
which at first were limited to oral administration.  As already mentioned, the 
low tolerance of the human gastrointestinal tract to the irritating action of the 
dye limited the possible daily dose to less than 3 gin. or between 1/8 and 1/10 
of the relative dose employed so successfully in mice.  As the relative ineffec- 
tiveness of this small oral dose became apparent to the workers making these 
field  trials,  parenteral  administration was  investigated.  The  method  em- 
ployed was intravenous infusion of a dilute solution (0.1 per cent) with total 
daily  doses of from 0.5 to 1.0 gin.  Total doses given ranged from 1.7 to 7.0 grn., 
with an average dose of 4.2 gm.  Although in 2 of 244 infusions  immediate 
reactions occurred and in about half the cases some venous thrombosis resulted, 
the limiting factor to continued therapy was the  marked  reduction in red 
blood cell count and hemoglobin associated with the use of MB.  Whole blood 
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of importance were the severity of the illness and the time of initiating treat- 
ment.  Because of shortage of the dye, cases classed as mild when first seen 
were not included and treatment was reserved for moderately and severely ill 
patients.  Study of the data suggests that the day of the disease on which the 
patient was first seen greatly  influenced the classification of the  patients into the 
above mentioned clinical groups, with the result  that treatment  appears to have 
been commenced much earlier in the moderately ill group (6 of 15 on the 3rd 
day and 10 by the 4th day) than in the severely ill patients (5 of 10 by the 6th 
day, one more on the 7th day, and all 10 by the 8th day).  The field observers 
concluded that the moderately ill patients were significantly  benefited by treat- 
ment but that the severely ill patients, because of the limits imposed by drug 
toxicity, were not able to tolerate enough dye to affect definitely the course of 
the disease.  The mortality figures, 2 in 26 treated and 5 in 33 strictly com- 
parable controls, were suggestive only.  The available report of this experience 
does not contain sufficient original data to permit independent analysis but it 
would appear likely that a perhaps better correlation exists between time of 
beginning treatment and the effect observed;  i.e.,  the earlier  the better. 
Results of the experimental treatment of mice with MB administered Suh- 
cutaneously serve to emphasize the difficulties imposed by dye toxicity.  They 
further suggest  that the chronic  toxicity of parenterally given  dye  is  rela- 
tively greater than that of dye administered orally, since, without consideration 
of the proportion of oral dye actually ahsorbed, it is clear that tolerated oral 
dosages are enormously effective, whereas  clearly non-toxic parenteral doses 
afford little protection against lethal outcome.  Finally, the apparent increase 
in susceptibility to the acute toxic effect of the dye in the late stages of the 
disease  carries  obvious  practical implications. 
It is evident from the foregoing that the practical application of MB as a 
therapeutic agent is  seriously  impeded by its  toxicity, although the  ~me 
evidence  does suggest that early treatment with tolerated doses is effective. 
Both the human experience (20) and careful animal studies (27) indicate that 
the "principal toxic effect of chronic nature is red blood cell destruction, per- 
haps due to a hemolytic effect.  That this can be successfully combatted by 
whole blood transfusions is suggested by observations made in the case of an 
infection acquired in the laboratory.  First treated on the 8th day of illness, the 
patient was maintained on a regime of parenteral MB for 8 days with a total 
.dose of 5.6 gin. in spite of severe drops in the hematocrit which necessitated 
four transfusions of whole blood,  s  However, a chemotherapeutic agent which 
requires  such  a  drastic adjuvant procedure  as  repeated blood  transfusions 
leaves  more than a  little to be desired. 
6  Case seen  in the New York Hospital  under  care of Dr. Walsh  McDermott.  Temperature 
decline began 2 days  after MB treatment  was started; patient  was afebrile on the 13th day of 
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Although both  the  clinical  and  experimental application  of  parenterally 
administered dye have been essentially discouraging  in  result, the potency of 
MB administered orally in the experimental disease is of such a high order of 
magnitude that further efforts to overcome or avoid the toxic effects are in- 
dicated.  One hope lies in the study of related compounds which might possess 
a similar degree of antirickettsial activity and less or no toxicity.  A number of 
observations  of this nature w~ be reported in the succeeding paper.  Another 
possible method, not yet put to test, would be to conjugate MB in various ways 
in~ the hope of suppressing the toxic factor and not the factor responsible for its 
chemotherapeutic effect.  That  these  two  factors may be  differentiated is 
suggested by the markedly  differing ratios of toxicity to effectiveness seen when 
the oral and subcutaneous routes of administration are employed.  The use of 
an,antidote constitutes a third approach.  It was recently demonstrated that 
sodium:  nitroprusside has a marked antidotal action against the acute toxicity 
of: MB  427).  We have investigated its possible activity against the chronic 
toxicity and have found, unfortunately, that only a minimal and questionably 
significant antidotal effect was achieved. 
Although in the experiments  reported in this paper and also in those of Mc- 
Limans and Grant (19) PABA was revealed as a far less potent agent than MB, 
improved methods of administration have resulted in the demonstration of a 
much greater effect  (26).  This improvement was apparently due to better 
maintenance of blood levels.  Also, clinical trials of orally administered PABA 
inhuman cases of scrub typhus in Burma have given very encouraging results 
(16).  In this paper it is not proposed  to discuss  the mode of action of the 
drugs examined but it may be stated that existing evidence suggests that the 
two agents, MB and PABA operate by different mechanisms.  The possibility 
of using these agents in combination, i.e. supplementing the activity of PABA 
with non-toxic doses of MB, presents itself and is  under investigation with, 
so far, encouraging  results. 
CONCLUSIONS 
Methylene blue (MB) and toluidine blue (TB) when administered in maxi- 
mum tolerated oral doses to mice and to cotton rats are highly effective in 
preventing the usual lethal outcome of intraperitoneally induced infections with 
R.  orientalis.  This activity is manifest even when dye administration is de- 
layed until a systemic infection has been well established.  IV[ethylene  blue is 
also effective in cerebral  infections in mice. 
The toxicity of MB, however, limits parenteral (subcutaneous)  administra- 
tion of the dye to dosage levels which are much less effective than the maximum 
tolerated oral levels.  The inability of mice to tolerate an adequately effective 
parenteral dose of ~¢IB suggests that the properties  of the dye responsible for its O.  L. PETERSON  AND J.  P. FOX  557 
toxicity may be  separated  from  those upon which  its  antirickettsial effect 
depends. 
The relationship between the response of mice to oral treatment with MB 
and such tactors as the size of the infecting dose and the times of initiation and 
of withdrawal of treatment may be summarized as follows: 
1.  With a constant infecting dose, the time of initiation of treatment largely 
determines the degree of therapeutic effect. 
2.  The  interval after infection beyond which further treatment does not 
increase the survival rate depends not upon the previous duration of treatment 
but  upon  the  size  of  the  infecting dose.  Paradoxically, treatment can  be 
discontinued sooner after a massive infecting dose than after a smaller one. 
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